Formations et évènements

European Lung Cancer Congress

26-29 Mars 2025
Paris

L'IFCT sera présent au congrès de l'ELCC qui aura lieu du 26 au 29 mars 2025.

Sites of relapse and subsequent therapy in the BR.31 phase 3 study of durvalumab vs placebo in resected stage IB-IIIA NSCLC
Virginie Westeel
Late breaking abstract - 28.03.2025
14:45 - 16:15
Room South Paris

Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study
Guillaume Tosato
Mini oral session - 28.03.2025
08:25 - 09:45
Room South Paris

Predictors of long-term response and survival in patients with extensive stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus chemotherapy in a real-world setting (IFCT-1905 CLINATEZO)
Lionel Falchero
Poster session - 28.03.2025
13:00 - 13:45
Poster area

Real World Data of lenvatinib in patients with Thymic epithelial tumors (TETs)
Álvaro López Gutiérrez
Poster session - 28.03.2025
13:00 - 13:45
Poster area

Real World Data of everolimus in patients with Thymic epithelial tumors (TETs)
Álvaro López Gutiérrez
Poster session - 28.03.2025
13:00 - 13:45
Poster area
Retour au calendrier des évènements

En savoir +

Programme